EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Defining the impact of flavivirus envelope protein glycosylation site mutations on sensitivity to broadly neutralizing antibodies

Maya Contreras, Jackson B Stuart, Lisa M Levoir, Laura Belmont, Leslie Goo iD

mBio · 2024

DOI: 10.1128/mbio.03048-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mBio, 2024. Verfasst von Maya Contreras und 4 weiteren Autor:innen. Beteiligte Einrichtung: Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA. Hauptthemen laut MEDLINE: Flavivirus, Zika Virus Infection, Zika Virus, Dengue Virus. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NCI NIH HHS, Fred Hutchinson Cancer Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antibodies that potently cross-neutralize Zika (ZIKV) and dengue (DENV) viruses are attractive to induce via vaccination to protect against these co-circulating flaviviruses. Structural studies have shown that viral envelope protein glycosylation is important for binding by one class of these so-called broadly neutralizing antibodies, but less is known about its effect on neutralization. Here, we investigated how envelope protein glycosylation site mutations impact the potency of broadly neutralizing antibodies against ZIKV and DENV. We found that glycan occupancy was not always predicted by an intact N-X-S/T sequence motif. Moreover, envelope protein glycosylation site mutations alter the potency of broadly neutralizing antibodies in a manner unexpected from their predicted binding mechanism as determined by existing structures. We therefore highlight the complex role and determinants of envelope protein glycosylation that should be considered in the design of vaccine antigens to elicit broadly neutralizing antibodies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FlavivirusZika Virus InfectionZika VirusDengue VirusDengueVaccinesHumansBroadly Neutralizing AntibodiesGlycosylationAntibodies, NeutralizingViral Envelope ProteinsAntibodies, ViralEpitopesMutationPolysaccharidesSerineThreonine

Stichwörter der Autor:innen

broadly neutralizing antibodiesenvelope glycosylationflavivirus

Substanzen

Broadly Neutralizing AntibodiesAntibodies, NeutralizingViral Envelope ProteinsAntibodies, ViralEpitopesPolysaccharidesSerineThreonineVaccines

Autor:innen und Institutionen

  • Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.
  • Graduate Program in Pathobiology, Department of Global Health, University of Washington, Seattle, Washington, USA.
  • Molecular and Cellular Biology Graduate Program, University of Washington, Seattle, Washington, USA.

ORCID-Profile: Leslie Goo

Förderung

  • NIAID NIH HHS
  • NCI NIH HHS
  • Fred Hutchinson Cancer Center
  • HHS | National Institutes of Health

Zitieren

APA

Contreras, M., Stuart, J. B., Levoir, L. M., Belmont, L., & Goo, L. (2024). Defining the impact of flavivirus envelope protein glycosylation site mutations on sensitivity to broadly neutralizing antibodies. mBio. https://doi.org/10.1128/mbio.03048-23

Vancouver

Contreras M, Stuart JB, Levoir LM, Belmont L, Goo L. Defining the impact of flavivirus envelope protein glycosylation site mutations on sensitivity to broadly neutralizing antibodies. mBio. 2024. doi:10.1128/mbio.03048-23

BibTeX
@article{Contreras2024,
  author = {Contreras, Maya and Stuart, Jackson B and Levoir, Lisa M and Belmont, Laura and Goo, Leslie},
  title = {Defining the impact of flavivirus envelope protein glycosylation site mutations on sensitivity to broadly neutralizing antibodies},
  journal = {mBio},
  year = {2024},
  doi = {10.1128/mbio.03048-23}
}
Kostenlos starten →